05Dec 2023
Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in the SPRINT Trial

Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in the SPRINT Trial

This prospective observational study, involving 8005 Systolic Blood Pressure Intervention Trial (SPRINT) participants, explored the association between longitudinal changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) during hypertension treatment and kidney function decline. A ≥25% decrease in NT-proBNP correlated with a slower estimated glomerular filtration rate (eGFR) decline, while a ≥25% increase was linked to faster eGFR decline and an increased risk of ≥30% decline in eGFR, particularly in those with baseline chronic kidney disease.

  • #nephrology

Like

Save

Share